Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · Real-Time Price · USD

4.130

-0.040 (-0.96%)

At close: Feb 18, 2026, 4:00 PM EST

4.273

+0.143 (3.45%)

After-hours: Feb 18, 2026, 4:18 PM EST

Arbutus Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	794	620	419	365	526	301
Market Cap Growth	25.88%	47.80%	15.00%	-30.72%	74.57%	74.57%
Enterprise Value	710	496	285	189	556	353
Last Close Price	4.17	3.27	2.50	2.33	3.89	3.55
PS Ratio	54.71	100.41	23.11	9.34	47.89	43.60
PB Ratio	10.34	6.36	3.95	2.66	3.11	2.96
P/TBV Ratio	10.32	6.36	3.95	2.66	3.11	-
EV/Sales Ratio	48.61	80.32	15.69	4.85	50.59	51.00
Debt / Equity Ratio	0.06	0.06	0.08	0.09	0.11	0.22
Net Debt / Equity Ratio	-1.15	-1.20	-1.17	-1.25	-1.02	-0.99
Net Debt / EBITDA Ratio	2.91	1.70	1.61	2.78	2.46	1.82
Net Debt / FCF Ratio	1.96	1.79	1.42	4.79	2.52	1.95
Asset Turnover	0.12	0.05	0.11	0.20	0.06	0.06
Quick Ratio	18.31	8.03	5.71	4.51	13.92	13.06
Current Ratio	18.80	8.15	5.87	4.60	14.32	13.39
Return on Equity (ROE)	-45.88%	-68.76%	-59.99%	-45.35%	-56.19%	-72.97%
Return on Assets (ROA)	-16.46%	-31.68%	-28.70%	-19.76%	-26.22%	-29.51%
Return on Capital Employed (ROCE)	-33.90%	-60.30%	-64.00%	-38.90%	-37.10%	-44.90%
Earnings Yield	-5.29%	-11.28%	-17.38%	-19.05%	-14.49%	-21.15%
FCF Yield	-5.68%	-10.50%	-20.74%	-9.84%	-12.99%	-17.14%
Buyback Yield / Dilution	-5.88%	-11.84%	-9.95%	-42.07%	-40.10%	-32.83%

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q